dostarlimab
gsk
['dostarlimab']
this study compared survival outcomes of #endometrialcancer patients receiving dostarlimab in a single-arm trial with an equivalent real-world cohort receiving current treatment in england. discover more insights during #asco2022. 
Global provider of Outsourced Clinical Research